Package Leaflet: Information for the user APO-go® PEN 10 mg/ml Solution for Injection * Apomorphine hydrochloride * Abbreviated
![A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2017/10/Figure_3_Patient_case_study_-a-personalised_approach_to.png)
A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY
![A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2017/10/Figure_1_The_history_of_apomorphine.png)
A Landmark Year for Apomorphine – Advancing Parkinson's Disease Management with New Clinical Evidence - touchNEUROLOGY
Package Leaflet: Information for the user APO-go® PEN 10 mg/ml Solution for Injection * Apomorphine hydrochloride * Abbreviated
![Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management](https://www.futuremedicine.com/cms/10.2217/nmt.14.17/asset/images/medium/figure1.gif)